0.4799
price down icon0.02%   -0.000100
pre-market  Vorhandelsmarkt:  .47   -0.0099   -2.06%
loading
Schlusskurs vom Vortag:
$0.48
Offen:
$0.4749
24-Stunden-Volumen:
241.54K
Relative Volume:
0.48
Marktkapitalisierung:
$25.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.16M
KGV:
-0.1616
EPS:
-2.97
Netto-Cashflow:
$-130.08M
1W Leistung:
+2.87%
1M Leistung:
-0.85%
6M Leistung:
-73.34%
1J Leistung:
-92.87%
1-Tages-Spanne:
Value
$0.444
$0.484
1-Wochen-Bereich:
Value
$0.444
$0.54
52-Wochen-Spanne:
Value
$0.404
$6.835

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
Firmenname
Alx Oncology Holdings Inc
Name
Telefon
650-466-7125
Name
Adresse
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Mitarbeiter
65
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ALXO's Discussions on Twitter

Vergleichen Sie ALXO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
0.4799 24.93M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-06 Hochstufung Jefferies Hold → Buy
2024-12-19 Herabstufung Jefferies Buy → Hold
2024-03-08 Herabstufung Stifel Buy → Hold
2023-12-08 Hochstufung Jefferies Hold → Buy
2021-12-22 Herabstufung Jefferies Buy → Hold
2021-09-30 Eingeleitet Stifel Buy
2021-05-05 Fortgesetzt Credit Suisse Outperform
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-06 Eingeleitet UBS Buy
2021-02-10 Eingeleitet H.C. Wainwright Buy
2020-08-11 Eingeleitet Cantor Fitzgerald Overweight
2020-08-11 Eingeleitet Credit Suisse Outperform
2020-08-11 Eingeleitet Jefferies Buy
2020-08-11 Eingeleitet Piper Sandler Overweight
Alle ansehen

Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten

pulisher
01:38 AM

ALX Oncology Holdings Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com

01:38 AM
pulisher
12:10 PM

Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com

12:10 PM
pulisher
Jul 22, 2025

What analysts say about ALX Oncology Holdings Inc. stockFree Predictions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives ALX Oncology Holdings Inc. stock priceFree Wealth Management Insights - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How ALX Oncology Holdings Inc. stock performs during market volatilitySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jun 16, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

ALX Oncology Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 31, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com

May 27, 2025
pulisher
May 24, 2025

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

UBS Group Issues Pessimistic Forecast for ALX Oncology (NASDAQ:ALXO) Stock Price - Defense World

May 23, 2025
pulisher
May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025
pulisher
May 22, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 21, 2025

ALXO: UBS Maintains 'Buy' Rating, Lowers Price Target | ALXO Sto - GuruFocus

May 21, 2025
pulisher
May 21, 2025

ALXO: UBS Maintains 'Buy' Rating, Lowers Price Target | ALXO Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

UBS Adjusts Price Target on ALX Oncology Holdings to $1 From $1.20, Maintains Buy Rating - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

ALX Oncology presents preclinical data, plans for ALX-2004 - BioWorld MedTech

May 21, 2025
pulisher
May 21, 2025

UBS Adjusts Price Target for ALX Oncology (ALXO) to $1 | ALXO St - GuruFocus

May 21, 2025

Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):